Cancer

Beleodaq approved for aggressive non-hodgkin lymphoma

(HealthDay)—Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

Jul 03, 2014
popularity 5 / 5 (2) | comments 0

CT scans lower lung cancer deaths, according to study

In response to a recent national study showing that CT scans in a select high-risk population lower lung cancer deaths, NewYork-Presbyterian/Weill Cornell Medical Center has launched a lung cancer screening ...

Jul 03, 2014
popularity not rated yet | comments 0

Enlightening cancer cells

Joint EMBO Journal paper by IST Austria and Vienna Medical University groups on engineered cell surface receptors activated by light. Small algal protein domains serve as synthetic light sensors in human ...

Jul 01, 2014
popularity 4.5 / 5 (2) | comments 0

Concern at lack of teenage patients in cancer trials

Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), ...

Jun 30, 2014
popularity not rated yet | comments 0